Showing results (1351-1360 of 1,823) with videos related to

Sort By:
Pageof 183
Transplantation and Cellular Therapy|August 29, 2026
Peripheral neuropathy after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and electrophysiologic featuresShuhei Kurosawa, Yukie Ishizaka, Kozue Tanaka, et al.
Transplantation and Cellular Therapy|September 8, 2026
ASTCT Consensus Grading for Toxicities after Immune Effector Cell TherapyMiguel-Angel Perales, Jorg Dietrich, Juliane Gust, et al.
Transplantation and Cellular Therapy|September 4, 2026
Conditioning Intensity and Outcomes in Pediatric HLA-Identical Transplant for Sickle Cell Disease: Comparison of MAC, RIC, and NMAHenna Butt, Minelys M Alicea Marrero, David Jacobsohn, et al.
Transplantation and Cellular Therapy|September 15, 2026
Incidence rates of immune-related adverse events and their correlation with response in hematological malignancies treated with Chimeric Antigen Receptor T-CellsZihao Li, Wuyuan Tan, Shaorong Lei, et al.
Transplantation and Cellular Therapy|September 18, 2026
HLA-DPB1 TCE mismatch vector differentially affects HCT outcomes in 10/10 and ≤9/10 HLA matched patients in the UKThomas R Turner, Charlotte A Cambridge, Jonathan A M Lucas, et al.
Transplantation and Cellular Therapy|September 16, 2026
Conversion from calcineurin inhibitor to ruxolitinib as GVHD prophylaxis during patients with transplant-associated thrombotic microangiopathyYan Zhang, Hanyin Liang, Zhiping Fan, et al.
Transplantation and Cellular Therapy|September 29, 2026
Lineage Plasticity-Mediated Resistance to CD7-Directed CAR-T Therapy in Relapsed/Refractory T-ALL/LBLJiahua Niu, Kun Wang, Shizhen Qiu, et al.
Transplantation and Cellular Therapy|October 22, 2026
Predictors and Outcomes of Immune Effector Cell Associated Neurotoxicity Syndrome in Patients Receiving Chimeric Antigen Receptor T Cell Therapy for Aggressive B-Cell Non-Hodgkin LymphomaVivek G Patel, Shakthi T Bhaskar, Stephen J Schuster, et al.
Transplantation and Cellular Therapy|October 28, 2026
Neutrophil Engraftment Timing after Single-Unit Cord Blood Transplantation as a Prognostic Marker of Transplant Outcomes Influenced by GVHD Prophylaxis: A nationwide, retrospective study by the Japanese Society for Transplantation and Cellular TherapyTakashi Oyama, Mitsuhiro Yuasa, Yoshihisa Miyamoto, et al.
Transplantation and Cellular Therapy|October 28, 2026
IDH2 p.R172 mutation Predicts Superior Outcomes in IDH-mutated Acute Myeloid Leukemia or Myelodysplastic Syndrome patients undergoing Allogeneic Hematopoietic Cell Transplantation: a retrospective study from the Grupo Español de Trasplante Hematopoyético y Terapia Celular (GETH-TC)Ana Pérez-González, Víctor Navarro, Manuel Guerreiro, et al.
Pageof 183